Share

Mail Facebook Twitter / X LinkedIn

Insight
Events
ACTV
Issues
Regions
- Africa
  - All Africa
  - Angola
  - Democratic Republic of the Congo
  - East Africa
  - Eritrea
  - Ethiopia
  - General Africa
  - Morocco
  - Nigeria
  - North & West Africa
  - Sahel
  - South & Central Africa
  - South Africa
  - Sudan
  - Somalia
- Americas
  - All Americas
  - United States and Canada
  - Latin America
  - Brazil
  - Caribbean
  - Colombia
  - Mexico
  - Central America
  - Venezuela
- Europe & Eurasia
  - All Europe & Eurasia
  - European Union
  - The Balkans
  - Belarus
  - The Caucasus
  - France
  - Germany
  - Greenland
  - Hungary
  - Italy
  - Moldova
  - Poland
  - Russia
  - Turkey
  - Ukraine
  - United Kingdom
- Indo-Pacific
  - All Indo-Pacific
  - Afghanistan
  - Australia
  - Bangladesh
  - China
  - India
  - Japan
  - Korea
  - Pakistan
  - Taiwan
- Middle East
  - All Middle East
  - The Gulf
  - North Africa
  - Iran
  - Iraq
  - Israel
  - Lebanon
  - Libya
  - Saudi Arabia
  - Syria
  - Yemen
Experts
- Find an expert
- Request a media interview
About
Donate

Insight
Events
ACTV
Issues
Regions
Experts
- Find an expert
- Request a media interview
About
Donate

Coronavirus India Politics & Diplomacy Resilience & Society South Asia

April 12, 2021

Nooruddin joins France24 to discuss COVID-19 vaccination in India

By Atlantic Council

original source

Related Experts: Irfan Nooruddin

Coronavirus India Politics & Diplomacy Resilience & Society South Asia

Join our network

Sign up to receive expert analysis from our community on the most important global issues, rapid insights on events as they unfold, and highlights of the Council's best work.

© 2026 Atlantic Council
All rights reserved.

Privacy Policy
Cookie Policy
Terms and conditions of use
Intellectual Independence Policy
Government Funding Review Process
Policy on donor acceptance and disclosure
Modern Day Slavery and Anti-Human Trafficking Policy
Photo credits

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.